Cardiff Oncology
CRDF
36 hedge funds and large institutions have $45.8M invested in Cardiff Oncology in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 2 closing their positions.
650% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 2
500% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 2
182% more capital invested
Capital invested by funds: $16.2M → $45.8M (+$29.6M)
38% more funds holding
Funds holding: 26 → 36 (+10)
64% less call options, than puts
Call options by funds: $101K | Put options by funds: $277K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
+$4.19M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.85M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.52M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$1.92M |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$943K |
| 2 |
PG
PEAK6 Group
Chicago,
Illinois
|
-$50K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$29.9K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$25.2K |
CRDF Hedge Fund Activity: Q1 2015 in Review
36 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2015, worth a combined $45.8M — up 182% from $16.2M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CRDF positions and 2 closed out — a net gain of 10 holders — while 15 added to existing stakes and 2 trimmed.
The largest buyer was Bridger Management, adding an estimated $4.19M. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $943K sold.
- 36 institutional investors held Cardiff Oncology (CRDF) as of Q1 2015, up from 26 in Q4 2014.
- Funds reported $45.8M of Cardiff Oncology stock for Q1 2015, up 182% quarter-over-quarter.
- 12 funds opened new Cardiff Oncology positions in Q1 2015 and 2 closed out, a net change of +10 holders.
- The largest Cardiff Oncology buyer in Q1 2015 was Bridger Management, an estimated $4.19M added.
- The largest Cardiff Oncology seller in Q1 2015 was Cambridge Investment Research Advisors, an estimated $943K sold.
Based on aggregated 13F filings for Q1 2015.